Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Attauabi M, Seidelin J, Burisch J. Gut 2021;70:2020-2022.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Attauabi M, Seidelin J, Burisch J. Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Gut 2021;70:2020-2022.
PMID: 33658323